These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31634354)

  • 1. Desmopressin and the risk of hyponatremia: A population-based cohort study.
    Fralick M; Schneeweiss S; Wallis CJD; Jung EH; Kesselheim AS
    PLoS Med; 2019 Oct; 16(10):e1002930. PubMed ID: 31634354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
    ten Doesschate T; Reichert LJ; Claassen JA
    Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
    Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS
    Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin acetate nasal spray for adults with nocturia.
    Cohn JA; Kowalik CG; Reynolds WS; Kaufman MR; Milam DF; Dmochowski RR; Wein AJ
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1281-1293. PubMed ID: 29048257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological complications caused by desmopressin in adults with nocturia].
    Steendam CM; Vincent HH; Kastelijn EA
    Ned Tijdschr Geneeskd; 2011; 155(29):A3273. PubMed ID: 21791132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis.
    Weatherall M
    Neurourol Urodyn; 2004; 23(4):302-5. PubMed ID: 15227644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
    Rembratt A; Riis A; Norgaard JP
    Neurourol Urodyn; 2006; 25(2):105-9. PubMed ID: 16304673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort study.
    Song M; Hong BS; Chun JY; Han JY; Choo MS
    Int Urol Nephrol; 2014 Aug; 46(8):1495-9. PubMed ID: 24595604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden.
    Ljung R
    Eur J Clin Pharmacol; 2008 Apr; 64(4):439-44. PubMed ID: 18180913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe hyponatremia and intranasal desmopressin-associated water intoxication in a female patient with diabetes insipidus and histiocytosis X].
    Monterrubio Villar J; Córdoba López A; Corcho Sánchez G
    Med Clin (Barc); 2003 Apr; 120(15):597. PubMed ID: 12729531
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term safety of desmopressin orally disintegrating tablets in men with nocturia due to nocturnal polyuria: Interim results of a specified drug use-results survey in Japan.
    Ogawa Y; Murata S; Kuramoto K; Nakano A
    Low Urin Tract Symptoms; 2024 May; 16(3):e12513. PubMed ID: 38616722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender difference in antidiuretic response to desmopressin.
    Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.
    Suvada K; Plantinga L; Vaughan CP; Markland AD; Mirk A; Burgio KL; Erni SM; Ali MK; Okosun I; Young H; Goode PS; Johnson TM
    Clin Ther; 2020 Dec; 42(12):e259-e274. PubMed ID: 33257091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Desmopressin therapy of nocturia in elderly patients may contribute to severe hyponatraemia].
    Sivalingam S; Sonne MP; Eldrup E
    Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
    Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
    J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.